Safety Assessment of d-Allulose 3-Epimerase from Genetically Modified Escherichia coli
For formulators tracking next generation sweeteners, d allulose keeps coming up. Now there’s a formal safety opinion to build on. EFSA’s panel has evaluated a food enzyme that make
For formulators tracking next-generation sweeteners, d-allulose keeps coming up. Now there’s a formal safety opinion to build on. EFSA’s panel has evaluated a food enzyme that makes d-allulose, and the conclusion is straightforward: no safety concerns under the intended conditions of use.
What this enzyme is
The enzyme is d-allulose 3-epimerase. The name alone tells you a lot. It is a 3-epimerase, which means it acts on carbon 3 of the sugar molecule. In this case, the enzyme converts D-fructose into d-allulose. That’s a useful trick. D-allulose is a rare sugar with a clean TFA-like sweetness and almost no calories. But producing it at commercial scale requires an enzyme that can reliably handle that conversion.
This particular version comes from a genetically modified strain of Escherichia coli. That matters for regulatory review. The food enzyme itself is derived from a production organism that was engineered to make the enzyme efficiently.
What the assessment covered
EFSA evaluated the enzyme as a food enzyme preparation. The intended application is sugar processing, specifically to produce specialty carbohydrates. The enzyme works in immobilized form. That design detail matters in real production because it lets processors reuse the enzyme and control the reaction more easily.
The assessment looked at the safety of the enzyme preparation under those intended conditions. The panel considered the source organism, the production process, and the likely exposure from its use. Their conclusion: the enzyme does not raise safety concerns when used as intended.
That’s not a blanket approval for every possible use. It’s a targeted safety clearance for a defined application. For an ingredient buyer, that’s the kind of clarity you want.
Key findings
Here’s what the assessment establishes:
| Aspect | Finding |
|---|---|
| Enzyme name | d-allulose 3-epimerase |
| Source organism | Genetically modified Escherichia coli |
| Catalyzed reaction | Epimerization of D-fructose to d-allulose |
| Enzyme form | Immobilized |
| Proposed use | Sugar processing to produce specialty carbohydrates |
| Safety conclusion | No safety concerns under intended conditions |
The immobilized form is worth emphasizing. Processors don’t have to deal with free enzyme in every batch. The enzyme sits on a support, catalyzes the reaction, and stays put. That simplifies downstream processing and gives formulators a cleaner path to the final sweetener.
What it means for manufacturers
This EFSA opinion gives you a regulatory reference point. If you are sourcing enzymes for d-allulose production, a positive safety evaluation from EFSA is exactly the type of evidence an ingredient buyer wants on file. You still need to verify your supply chain and confirm that your supplier’s manufacturing conditions match the evaluation. But the safety question surrounding this enzyme has an answer.
For product developers, the practical takeaway is about supply confidence. The enzyme works on a well-known substrate, D-fructose, and turns it into a desirable specialty sugar. It does so in a fixed, process-friendly form. That combination addresses two common concerns: reaction efficiency and downstream handling.
There’s also a labeling and documentation angle. If your d-allulose product relies on this enzyme, you’ll want the technical file to reflect the approved source organism and the intended use. Buyers and auditors will look for that alignment.
FAQ
Is this enzyme safe? Yes, according to the EFSA panel. They concluded that the enzyme raises no safety concerns under the intended conditions of use.
What does the enzyme actually do? It catalyzes the epimerization of D-fructose to d-allulose. It is used in immobilized form in sugar processing.
What is the source organism? The enzyme is produced from a genetically modified strain of Escherichia coli.
This isn’t a speculative finding. It’s a published safety assessment with a clear regulatory conclusion. If you’re making decisions about d-allulose production ingredients, this one goes in the “approved” column.
Need Allulose Application Guidance?
Our technical team can help evaluate allulose for sugar reduction, texture, browning, and label-planning projects.